Skip to content

OCULUS INC.: 10-Q filed 2025-11-12

What OCULUS INC. reported in its quarterly report filed 2025-11-12 (fiscal Q3 2025): 18 published measures, 54 facts as tagged in accession 0001437749-25-034320.

This filing

Form
10-Q (quarterly report)
Filed
2025-11-12
Fiscal period
fiscal Q3 2025
Accession
0001437749-25-034320 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All OCULUS INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-09-3025,240USD
At 2024-12-3139,540USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-09-30-667,236USD
At 2025-06-30-572,300USD
At 2024-12-31-409,473USD
At 2024-09-30-316,737USD
At 2024-06-30-247,307USD
At 2023-12-31-89,768USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-09-3015,229USD
At 2024-12-3111,718USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-93,123USD92
2025-01-01 to 2025-09-30-247,751USD273
2024-07-01 to 2024-09-30-69,143USD92
2024-01-01 to 2024-09-30-231,930USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-09-3013,523USD273
2024-01-01 to 2024-09-30-152,080USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-09-30-48,961,757USD
At 2024-12-31-48,714,006USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-07-01 to 2025-09-3091,422,569shares92
2025-01-01 to 2025-09-3091,422,569shares273
2024-07-01 to 2024-09-3091,422,569shares92
2024-01-01 to 2024-09-3091,422,569shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-07-01 to 2025-09-300USD/shares92
2025-01-01 to 2025-09-300USD/shares273
2024-07-01 to 2024-09-300USD/shares92
2024-01-01 to 2024-09-300USD/shares274

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-01-01 to 2025-09-300USD273
2024-01-01 to 2024-09-305,969USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-09-30692,476USD
At 2024-12-31449,013USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2025-07-01 to 2025-09-3077,852USD92
2025-01-01 to 2025-09-30202,104USD273
2024-07-01 to 2024-09-3051,596USD92
2024-01-01 to 2024-09-30144,835USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-07-01 to 2025-09-30276USD92
2025-01-01 to 2025-09-30736USD273
2024-07-01 to 2024-09-301,455USD92
2024-01-01 to 2024-09-306,186USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-09-3091,422,569shares
At 2024-12-3191,422,569shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-09-301,485,000USD
At 2024-12-311,485,000USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2025-09-3010,011USD
At 2024-12-3127,822USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-94,936USD92
2025-01-01 to 2025-09-30-257,763USD273
2024-07-01 to 2024-09-30-69,720USD92
2024-01-01 to 2024-09-30-232,938USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-3042,250USD92
2025-01-01 to 2025-09-3066,580USD273
2024-07-01 to 2024-09-3018,859USD92
2024-01-01 to 2024-09-3045,887USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2025-01-01 to 2025-09-300USD273
2024-01-01 to 2024-09-300USD274

Inspect the source

Entity
OCULUS INC. / CIK 0001107280
Captured
2026-09-20T05:23:31.283Z
SEC response SHA-256
63097be359140327b7dc122e8108372f9ed2c94e74a857e52ba6271b22125468

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001107280.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))